These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 15285183

  • 1. Oxidative stress in hemodialysis--postdialytic changes.
    Dakshinamurty KV, Rao PV, Saibaba KS, Sheela RB, Sreekrishna V, Venakataramana G, Shyam C, Jayaseelan L.
    Clin Lab; 2003; 49(5-6):255-61. PubMed ID: 15285183
    [Abstract] [Full Text] [Related]

  • 2. Free radicals and oxidative stress challenge dialysis patients: effects of two different membranes.
    Biasioli S, Schiavon R, Petrosino L, Cavallini L, Zambello A, De Fanti E, Giavarina D.
    ASAIO J; 1997; 43(5):M766-72. PubMed ID: 9360150
    [Abstract] [Full Text] [Related]

  • 3. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
    Cavdar C, Temiz A, Yeniçerioğlu Y, Calişkan S, Celik A, Sifil A, Onvural B, Camsari T.
    Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
    [Abstract] [Full Text] [Related]

  • 4. Oxidative stress in haemodialysis--intradialytic changes.
    Srinivasa Rao PV, Dakshinamurty KV, Saibaba KS, Raghavan MS, Vijayabhaskar M, Sreekrishna V, Ambekar JG, Jayaseelan L.
    Redox Rep; 2001; 6(5):303-9. PubMed ID: 11778848
    [Abstract] [Full Text] [Related]

  • 5. Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes.
    Wu CC, Chen JS, Wu WM, Liao TN, Chu P, Lin SH, Chuang CH, Lin YF.
    Nephrol Dial Transplant; 2005 Jun; 20(6):1134-9. PubMed ID: 15814542
    [Abstract] [Full Text] [Related]

  • 6. Oxidative stress and erythrocyte integrity in end-stage renal failure patients hemodialysed using a vitamin E-modified membrane.
    Westhuyzen J, Saltissi D, Stanbury V.
    Ann Clin Lab Sci; 2003 Jun; 33(1):3-10. PubMed ID: 12661892
    [Abstract] [Full Text] [Related]

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 8. Oral vitamin C supplementation in hemodialysis patients and its effect on the plasma level of oxidized ascorbic acid and Cu/Zn superoxide dismutase, an oxidative stress marker.
    Washio K, Inagaki M, Tsuji M, Morio Y, Akiyama S, Gotoh H, Gotoh T, Gotoh Y, Oguchi K.
    Nephron Clin Pract; 2008 Nov; 109(2):c49-54. PubMed ID: 18544955
    [Abstract] [Full Text] [Related]

  • 9. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM, Youssef AM, Zayoon MY.
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical and analytical changes in hemodialysis without acetate].
    Coll E, Pérez-García R, Rodríguez-Benítez P, Ortega M, Martínez Miguel P, Jofré R, López-Gómez JM.
    Nefrologia; 2007 Oct; 27(6):742-8. PubMed ID: 18336105
    [Abstract] [Full Text] [Related]

  • 12. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity.
    Goi G, Massaccesi L, Baquero Herrera CJ, Musetti C, Ciurlino D, Cusi D, Bertoli S.
    J Nephrol; 2009 Oct; 22(5):630-6. PubMed ID: 19809996
    [Abstract] [Full Text] [Related]

  • 13. Use of ascorbate-rich dialysate to attenuate oxidative stress in maintenance hemodialysis patients.
    Shi XF, Ding F, Zhu QY, Xue J, Lu FM, Gu Y, Lin ST.
    Ren Fail; 2005 Oct; 27(2):213-9. PubMed ID: 15807188
    [Abstract] [Full Text] [Related]

  • 14. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
    Lucchi L, Bergamini S, Iannone A, Perrone S, Stipo L, Olmeda F, Caruso F, Tomasi A, Albertazzi A.
    Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Influence of vitamin E and N-acetylcysteine on intracellular oxidative stress in T lymphocytes in children treated with dialysis].
    Zaniew M, Zachwieja J, Warzywoda A, Stefaniak E, Runowski D, Lewandowska-Stachowiak M.
    Wiad Lek; 2005 Jan; 58 Suppl 1():58-65. PubMed ID: 16060087
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of the initiation of renal replacement therapy on lipid profile and oxidative stress during the first 6 months of treatment.
    Diepeveen SH, Verhoeven GH, van der Palen J, Dikkeschei BL, van Tits BL, Kolsters G, Offerman JJ, Bilo HJ, Stalenhoef AF.
    Clin Chim Acta; 2005 Nov; 361(1-2):112-8. PubMed ID: 16122722
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.